Rinat Maksyutov, General Director of the State Scientific Center for Virology and Biotechnology “Vector” of Rospotrebnadzor, said that the preliminary results of post-registration studies of the EpiVacCorona vaccine will be at the end of April.
As he noted in an interview RIA Novosti, all volunteers participating in the study are already vaccinated – 75% with the vaccine, 25% received a placebo.
“At the end of April, preliminary results will be summed up for all eight centers where post-registration studies are carried out. Until that time, it is premature to talk about concrete figures, ”he said.
Maksyutov said that the study is being conducted among 3 thousand volunteers. All have already passed 42 days after the injection of the drug.
It is noted that the total duration of observation of volunteers will be 180 days.
Earlier, the head of Vector told about the peculiarities of revaccination with EpiVacCorona.
Source: RT на русском by russian.rt.com.
*The article has been translated based on the content of RT на русском by russian.rt.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!
*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.
*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!